Literature DB >> 31158804

MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?

Marianthi Breza1, Georgios Koutsis2, John S Tzartos3, Georgios Velonakis4, Maria Eleftheria Evangelopoulos5, Dimitrios Tzanetakos5, Katerina Karagiorgou6, Georgia Angelopoulou7, Dimitrios Kasselimis8, Constantin Potagas9, Maria Anagnostouli10, Leonidas Stefanis11, Constantinos Kilidireas12.   

Abstract

MOG-antibody associated demyelinating disease is a new emerging diagnostic entity. Recently, international recommendations for testing of anti-MOG antibodies were published. Herein, we describe a case of anti-MOG antibody-associated demyelinating disease initially diagnosed as typical MS, and, at presentation, not fulfilling the proposed recommendations. This case highlights the expanding spectrum of anti-MOG antibody-associated demyelinating disease, illustrating the distinct and overlapping features of MS and MOG-antibody associated demyelinating disease, providing evidence that on rare occasions these recommendations may prove too restrictive.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-MOG antibodies; Anti-MOG antibody testing; MOG antibody-associated demyelination; Multiple sclerosis

Mesh:

Substances:

Year:  2019        PMID: 31158804     DOI: 10.1016/j.msard.2019.05.021

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  3 in total

1.  Clinical characteristics of MOG antibody disease: two case reports.

Authors:  Yujia Guan; Zunwei Zhang; Mingming Li; Miao Shi; Hui Deng
Journal:  Neurol Sci       Date:  2021-02-10       Impact factor: 3.307

Review 2.  Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD).

Authors:  Yunjie Li; Xia Liu; Jingxuan Wang; Chao Pan; Zhouping Tang
Journal:  Front Aging Neurosci       Date:  2022-03-15       Impact factor: 5.750

3.  Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity?

Authors:  Yang Zheng; Meng-Ting Cai; Er-Chuang Li; Wei Fang; Chun-Hong Shen; Yin-Xi Zhang
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.